RxDoctor Payments DataLook up a doctor →

Herman Kado, MD

Cardiovascular Disease · Southfield, MINPI 1033367362

Payments from drug & device makers

$766,377in general payments, 2019–2025

Across 1,164 payments — averaging $658.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$518K
  • Imperative Care, Inc$142K
  • Regeneron$41K
  • Stryker$35K
  • Angiodynamics, Inc.$12K
  • Abbott$5K
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Inari Medical, Inc.400$518,438
Imperative Care, Inc4$141,649
Regeneron13$41,350
Stryker13$35,423
Angiodynamics, Inc.3$12,033
Abbott72$4,822
Amgen70$1,167
Novartis76$1,153
Boston Scientific10$1,096
Merck51$1,061
AstraZeneca52$923
Johnson & Johnson(2 entities)61$852
Esperion Therapeutics, Inc.46$681
Endologix LLC27$663
Alnylam Pharmaceuticals Inc.46$597
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)25$413
Pfizer21$358
Boehringer Ingelheim17$339
Lexicon Pharmaceuticals, Inc.11$337
Amarin Pharma, Inc.19$300
E.r. Squibb & Sons, L.L.C.17$267
Lilly USA, LLC14$216
Regeneron Healthcare Solutions, Inc.10$150
Medtronic5$130
W. L. Gore & Associates, Inc.1$129
Novo Nordisk5$120
Inquis Medical, Inc.1$118
Kestra Medical Technology Services, Inc.4$116
Edwards Lifesciences5$105
Smith+Nephew1$99
Sanofi-aventis U.S. LLC5$83
Kiniksa Pharmaceuticals, Ltd.3$82
Actelion Pharmaceuticals US, Inc.3$73
Venclose Inc.1$72
Chiesi USA, Inc.4$68
Bridgebio Pharma, Inc.3$61
Scpharmaceuticals Inc.3$60
Lundbeck LLC3$57
Biosense Webster, Inc.1$55
Cardiovascular Systems Inc.2$54
Tactile Systems Technology Inc4$52
Bardy Diagnostics, Inc.3$48
Kiniksa Pharmaceuticals International, PLC2$47
Penumbra, Inc.3$46
Bayer2$46
Recor Medical Inc2$43
Vital Connect, Inc1$38
Abiomed2$35
Baxter Healthcare2$31
Heartflow, Inc.2$29
Kowa Pharmaceuticals America, Inc.2$27
Bard Peripheral Vascular, Inc.1$23
Medicomp Inc1$19
Lantheus Medical Imaging, Inc.1$18
Daiichi Sankyo Inc.1$17
Cordis US CORP.1$17
Irhythm Technologies, Inc.1$16
Philips North America LLC1$14
Bsn Medical Inc1$14
Kerecis Limited1$13

How this compares

$766,377 in reported general payments places this provider in the 95th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan →

Medicare billing

Part B allowed, 2024
$916,725
Medicare patients
1,237
Services billed
4,970

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Southfield

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →